Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shu-Chih Su

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Statistics in Medicine|March 23, 2012
An efficient alternative to the stratified Cox model analysisDevan V Mehrotra, Shu-Chih Su, Xiaoming Li
Biostatistics (Oxford, England)|August 30, 2008
Modified test statistics by inter-voxel variance shrinkage with an application to f MRIShu-Chih Su, Brian Caffo, Elizabeth Garrett-Mayer, et al.
Journal of Public Health Management and Practice : JPHMP|June 17, 2008
County lung cancer mortality: a decision tree model for control and preventionNorma Kanarek, Brian Fitzek, Shu-Chih Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Spatial analyses identify the geographic source of patients at a National Cancer Institute Comprehensive Cancer CenterShu-Chih Su, Norma Kanarek, Michael G Fox, et al.
Human Vaccines & Immunotherapeutics|July 20, 2018
A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL)Zoran Popmihajlov, Lei Pang, Elizabeth Brown, et al.
The Journal of Infectious Diseases|May 15, 2014
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curvePeter B Gilbert, Erin E Gabriel, Xiaopeng Miao, et al.
The Journal of Infectious Diseases|May 20, 2015
Reply to DunningPeter B Gilbert, Erin E Gabriel, Michael G Hudgens, et al.
Vaccine|May 13, 2015
Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroidsAmy F Russell, Janie Parrino, Chester L Fisher, et al.
Human Vaccines|October 29, 2010
Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years oldC Raina MacIntyre, Tony Egerton, Malcolm McCaughey, et al.
The Journal of Infectious Diseases|October 11, 2015
Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older AdultsMyron J Levin, Kenneth E Schmader, Lei Pang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Statistics in Medicine|March 23, 2012
An efficient alternative to the stratified Cox model analysisDevan V Mehrotra, Shu-Chih Su, Xiaoming Li
Biostatistics (Oxford, England)|August 30, 2008
Modified test statistics by inter-voxel variance shrinkage with an application to f MRIShu-Chih Su, Brian Caffo, Elizabeth Garrett-Mayer, et al.
Journal of Public Health Management and Practice : JPHMP|June 17, 2008
County lung cancer mortality: a decision tree model for control and preventionNorma Kanarek, Brian Fitzek, Shu-Chih Su, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2010
Spatial analyses identify the geographic source of patients at a National Cancer Institute Comprehensive Cancer CenterShu-Chih Su, Norma Kanarek, Michael G Fox, et al.
Human Vaccines & Immunotherapeutics|July 20, 2018
A post hoc analysis utilizing the FDA toxicity grading scale to assess injection site adverse events following immunization with the live attenuated Zoster Vaccine (ZVL)Zoran Popmihajlov, Lei Pang, Elizabeth Brown, et al.
The Journal of Infectious Diseases|May 15, 2014
Fold rise in antibody titers by measured by glycoprotein-based enzyme-linked immunosorbent assay is an excellent correlate of protection for a herpes zoster vaccine, demonstrated via the vaccine efficacy curvePeter B Gilbert, Erin E Gabriel, Xiaopeng Miao, et al.
The Journal of Infectious Diseases|May 20, 2015
Reply to DunningPeter B Gilbert, Erin E Gabriel, Michael G Hudgens, et al.
Vaccine|May 13, 2015
Safety, tolerability, and immunogenicity of zoster vaccine in subjects on chronic/maintenance corticosteroidsAmy F Russell, Janie Parrino, Chester L Fisher, et al.
Human Vaccines|October 29, 2010
Concomitant administration of zoster and pneumococcal vaccines in adults ≥60 years oldC Raina MacIntyre, Tony Egerton, Malcolm McCaughey, et al.
The Journal of Infectious Diseases|October 11, 2015
Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older AdultsMyron J Levin, Kenneth E Schmader, Lei Pang, et al.
Pageof 2